- Home
- PTGX vs TENB Comparison
PTGX vs TENB Comparison
Compare PTGX & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- TENB
- Stock Information
- Founded
- PTGX 2006
- TENB 2002
- Country
- PTGX United States
- TENB United States
- Employees
- PTGX N/A
- TENB N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- TENB Computer Software: Prepackaged Software
- Sector
- PTGX Health Care
- TENB Technology
- Exchange
- PTGX Nasdaq
- TENB Nasdaq
- Market Cap
- PTGX 4.0B
- TENB 3.5B
- IPO Year
- PTGX 2016
- TENB 2018
- Fundamental
- Price
- PTGX $79.21
- TENB $27.42
- Analyst Decision
- PTGX Strong Buy
- TENB Buy
- Analyst Count
- PTGX 9
- TENB 18
- Target Price
- PTGX $78.11
- TENB $39.88
- AVG Volume (30 Days)
- PTGX 1.6M
- TENB 1.2M
- Earning Date
- PTGX 10-31-2025
- TENB 10-29-2025
- Dividend Yield
- PTGX N/A
- TENB N/A
- EPS Growth
- PTGX N/A
- TENB N/A
- EPS
- PTGX 0.80
- TENB N/A
- Revenue
- PTGX $209,180,000.00
- TENB $974,603,000.00
- Revenue This Year
- PTGX N/A
- TENB $11.66
- Revenue Next Year
- PTGX $140.23
- TENB $7.86
- P/E Ratio
- PTGX $99.17
- TENB N/A
- Revenue Growth
- PTGX N/A
- TENB 11.05
- 52 Week Low
- PTGX $33.31
- TENB $27.03
- 52 Week High
- PTGX $93.25
- TENB $45.45
- Technical
- Relative Strength Index (RSI)
- PTGX 60.22
- TENB 33.03
- Support Level
- PTGX $75.44
- TENB $28.55
- Resistance Level
- PTGX $80.43
- TENB $29.36
- Average True Range (ATR)
- PTGX 2.48
- TENB 0.79
- MACD
- PTGX -0.36
- TENB -0.23
- Stochastic Oscillator
- PTGX 74.63
- TENB 11.19
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.